NYSE:TXMD
TherapeuticsMD Stock News
$2.22
+0.100 (+4.72%)
At Close: May 17, 2024
TXMD Stock: The News Giving TherapeuticsMD Shares a Shot in the Arm Friday
11:16am, Friday, 09'th Apr 2021
TherapeuticsMD (TXMD) stock is up on Friday after announcing approval for one of its hormone treatments in two parts of Europe. The post TXMD Stock: The News Giving TherapeuticsMD Shares a Shot in the
TherapeuticsMD Stock Price Increased Over 10% Pre-Market: Why It Happened
07:18am, Friday, 09'th Apr 2021
The stock price of TherapeuticsMD Inc (NASDAQ: TXMD) increased by over 10% pre-market. This is why it happened.
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women's healthcare company, and Theramex, a dedicated women's health company, announced that BIJUVE® has
7 Reddit Penny Stocks Seeing the Most Chatter Today
12:40pm, Thursday, 18'th Mar 2021
Retail investors over on Reddit Penny Stocks are showing interest in quite a few interesting players today that investors will want to note. The post 7 Reddit Penny Stocks Seeing the Most Chatter Toda
EU & UK Conclude Decentralised Procedure Approval for Bijuva® (Estradiol & Progesterone) Capsules for Hormone Replacement Therapy
04:28am, Wednesday, 03'rd Mar 2021
LONDON--(BUSINESS WIRE)--Theramex, a global company specialised in women's health, announced today the Decentralised Procedure approval in several EU countries and the UK of BIJUVA® (1 mg estradiol /
TherapeuticsMD, Inc. (TXMD) CEO Robert Finizio on Q4 2020 Results - Earnings Call Transcript
01:13pm, Tuesday, 02'nd Mar 2021
TherapeuticsMD, Inc. (TXMD) CEO Robert Finizio on Q4 2020 Results - Earnings Call Transcript
TherapeuticsMD (TXMD) Reports Q4 Loss, Tops Revenue Estimates
09:05am, Tuesday, 02'nd Mar 2021
TherapeuticsMD (TXMD) delivered earnings and revenue surprises of -50.00% and 6.12%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Recap: TherapeuticsMD Q4 Earnings
07:22am, Tuesday, 02'nd Mar 2021
Shares of TherapeuticsMD (NASDAQ:TXMD) rose 9.3% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 21.05% over the past year to ($0.15), which miss
TherapeuticsMD Announces Fourth Quarter and Full-Year 2020 Financial Results
07:00am, Tuesday, 02'nd Mar 2021
BOCA RATON, Fla.--(BUSINESS WIRE)--TXMD net product revenue in 2020 increased 84% over 2019; conference call at 8:30am ET today to discuss financial and business results for 2020.
TherapeuticsMD Announces Participation in Upcoming Investor Conferences
07:00am, Monday, 01'st Mar 2021
BOCA RATON, Fla.--(BUSINESS WIRE)--March Conferences
TherapeuticsMD (TXMD) Outpaces Stock Market Gains: What You Should Know
06:56pm, Wednesday, 24'th Feb 2021
TherapeuticsMD (TXMD) closed the most recent trading day at $1.63, moving +1.24% from the previous trading session.
TXMD Stock Price Increases Over 35% Pre-Market: Why It Happened
07:01am, Monday, 08'th Feb 2021
The stock price of TherapeuticsMD Inc (NASDAQ: TXMD) is trading at over 35% pre-market. This is why it happened.
TherapeuticsMD: Annovera May Save The Day
10:57am, Thursday, 04'th Feb 2021
TherapeuticsMD: Annovera May Save The Day
10 Robinhood Stocks With the Highest Short Interest
06:06am, Sunday, 31'st Jan 2021
Pessimists have piled into these companies, but that doesn't seem to be fazing millennial investors one bit.
10 Short Squeeze Candidates Under $10
08:36am, Saturday, 30'th Jan 2021
The movement of retail traders against hedge funds has caused several stocks to spike. Many of the top movers have been stocks that have a high percentage of their floated shares short, causing what's